Dr. Reddy's Labs Files 6-K Report
Ticker: RDY · Form: 6-K · Filed: Jun 20, 2025 · CIK: 1135951
Sentiment: neutral
Topics: sec-filing, 6-k, foreign-private-issuer
Related Tickers: RDY
TL;DR
RDY filed a 6-K, standard procedure for foreign issuers. Nothing new here.
AI Summary
Dr. Reddy's Laboratories Limited filed a Form 6-K on June 20, 2025, reporting as a foreign private issuer. The company, based in Hyderabad, India, is a pharmaceutical preparations manufacturer. This filing indicates they will file annual reports under Form 20-F.
Why It Matters
This filing is a routine report for foreign private issuers, providing an update on the company's regulatory status and reporting requirements.
Risk Assessment
Risk Level: low — This is a routine administrative filing and does not contain new financial or operational information that would typically impact risk.
Key Players & Entities
- Dr. Reddy's Laboratories Limited (company) — Registrant
- 0001575872-25-000414 (filing_id) — Accession Number
- 20250620 (date) — Filing Date
- Hyderabad, India (location) — Company Headquarters
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, typically used to provide information that the company makes or is required to make public in its home country.
Which form does Dr. Reddy's Laboratories Limited indicate it will use for its annual reports?
Dr. Reddy's Laboratories Limited indicates it will file annual reports under cover of Form 20-F.
What is the filing date of this Form 6-K?
The filing date of this Form 6-K is June 20, 2025.
Where is Dr. Reddy's Laboratories Limited headquartered?
Dr. Reddy's Laboratories Limited is headquartered in Hyderabad, Telangana, India.
What is the SIC code for Dr. Reddy's Laboratories Limited?
The Standard Industrial Classification (SIC) code for Dr. Reddy's Laboratories Limited is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 20, 2025 regarding DR REDDYS LABORATORIES LTD (RDY).